Browder IW - Search Results

1

Development, physicochemical characterization and preclinical efficacy evaluation of a water soluble glucan sulfate derived from Saccharomyces cerevisiae.

Williams DL, Pretus HA, McNamee RB, Jones EL, Ensley HE, Browder IW, Di Luzio NR. Williams DL, et al. Among authors: browder iw. Immunopharmacology. 1991 Nov-Dec;22(3):139-55. doi: 10.1016/0162-3109(91)90039-2. Immunopharmacology. 1991. PMID: 1774155

2

Development of a water-soluble, sulfated (1-->3)-beta-D-glucan biological response modifier derived from Saccharomyces cerevisiae.

Williams DL, Pretus HA, McNamee RB, Jones EL, Ensley HE, Browder IW. Williams DL, et al. Among authors: browder iw. Carbohydr Res. 1992 Nov 4;235:247-57. doi: 10.1016/0008-6215(92)80093-g. Carbohydr Res. 1992. PMID: 1473107

3

A method for the solubilization of a (1----3)-beta-D-glucan isolated from Saccharomyces cerevisiae.

Williams DL, McNamee RB, Jones EL, Pretus HA, Ensley HE, Browder IW, Di Luzio NR. Williams DL, et al. Among authors: browder iw. Carbohydr Res. 1991 Oct 14;219:203-13. doi: 10.1016/0008-6215(91)89052-h. Carbohydr Res. 1991. PMID: 1804535

4

Isolation, physicochemical characterization and preclinical efficacy evaluation of soluble scleroglucan.

Pretus HA, Ensley HE, McNamee RB, Jones EL, Browder IW, Williams DL. Pretus HA, et al. Among authors: browder iw. J Pharmacol Exp Ther. 1991 Apr;257(1):500-10. J Pharmacol Exp Ther. 1991. PMID: 1902259

5

Immunization against Trypanosoma cruzi: adjuvant effect of glucan.

Williams DL, Yaeger RG, Pretus HA, Browder IW, McNamee RB, Jones EL. Williams DL, et al. Among authors: browder iw. Int J Immunopharmacol. 1989;11(4):403-10. doi: 10.1016/0192-0561(89)90087-8. Int J Immunopharmacol. 1989. PMID: 2506140

6

The role of complement in glucan-induced protection against septic shock.

Williams DL, Sherwood ER, Browder IW, McNamee RB, Jones EL, Di Luzio NR. Williams DL, et al. Among authors: browder iw. Circ Shock. 1988 May;25(1):53-60. Circ Shock. 1988. PMID: 3042187

7

Pre-clinical safety evaluation of soluble glucan.

Williams DL, Sherwood ER, Browder IW, McNamee RB, Jones EL, Di Luzio NR. Williams DL, et al. Among authors: browder iw. Int J Immunopharmacol. 1988;10(4):405-14. doi: 10.1016/0192-0561(88)90127-0. Int J Immunopharmacol. 1988. PMID: 3262594

8

Effect of glucan on neutrophil dynamics and immune function in Escherichia coli peritonitis.

Williams DL, Sherwood ER, Browder IW, McNamee RB, Jones EL, Rakinic J, Di Luzio NR. Williams DL, et al. Among authors: browder iw. J Surg Res. 1988 Jan;44(1):54-61. doi: 10.1016/0022-4804(88)90122-9. J Surg Res. 1988. PMID: 3275833

9

Soluble glucan and lymphokine-activated killer (LAK) cells in the therapy of experimental hepatic metastases.

Sherwood ER, Williams DL, McNamee RB, Jones EL, Browder IW, Di Luzio NR. Sherwood ER, et al. Among authors: browder iw. J Biol Response Mod. 1988 Apr;7(2):185-98. J Biol Response Mod. 1988. PMID: 3283299

10

Enhancement of interleukin-1 and interleukin-2 production by soluble glucan.

Sherwood ER, Williams DL, McNamee RB, Jones EL, Browder IW, Di Luzio NR. Sherwood ER, et al. Among authors: browder iw. Int J Immunopharmacol. 1987;9(3):261-7. doi: 10.1016/0192-0561(87)90049-x. Int J Immunopharmacol. 1987. PMID: 3497113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page